Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.

Balestre E, Eholié SP, Lokossue A, Sow PS, Charurat M, Minga A, Drabo J, Dabis F, Ekouevi DK, Thiébaut R; International epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration.

AIDS. 2012 May 15;26(8):951-7. doi: 10.1097/QAD.0b013e3283528ad4.

2.

Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.

Desmonde S, Dicko F, Koueta F, Eboua T, Balestre E, Amani-Bosse C, Aka EA, Lawson-Evi K, Amorissani-Folquet M, Kouakou K, Koumakpai S, Renner L, Signaté Sy H, Leroy V; IeDEA West Africa Paediatric Collaboration.

AIDS. 2014 Jul 17;28(11):1645-55. doi: 10.1097/QAD.0000000000000272.

3.

First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration.

Drylewicz J, Eholie S, Maiga M, Zannou DM, Sow PS, Ekouevi DK, Peterson K, Bissagnene E, Dabis F, Thiébaut R; International epidemiologic Databases to Evaluate AIDS (IeDEA) West Africa Collaboration.

AIDS. 2010 Apr 24;24(7):1043-50.

4.

Effect of sex and age on outcomes among HIV-2-infected patients starting antiretroviral therapy in West Africa.

Tchounga BK, Hønge BL, Eholie SP, Coffie PA, Jespersen S, Wejse C, Dabis F, Geoffrey GS, Ekouevi DK; IeDEA West Africa collaboration.

AIDS. 2016 Nov 13;30(17):2707-2714.

5.

Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.

Imaz A, Olmo M, Peñaranda M, Gutiérrez F, Romeu J, Larrousse M, Domingo P, Oteo JA, Curto J, Vilallonga C, Masiá M, López-Aldeguer J, Iribarren JA, Podzamczer D; STOPAR study team.

Antivir Ther. 2013;18(1):125-30. doi: 10.3851/IMP2249. Epub 2012 Jul 18.

PMID:
22805174
6.

Incidence of pregnancy after antiretroviral therapy initiation and associated factors in 8 West African countries.

Burgos-Soto J, Balestre E, Minga A, Ajayi S, Sawadogo A, Zannou MD, Leroy V, Ekouevi DK, Dabis F, Becquet R; IeDEA West Africa Collaboration.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e45-54. doi: 10.1097/QAI.0000000000000279.

7.

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.

Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R; Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

HIV Med. 2017 Jan;18(1):33-44. doi: 10.1111/hiv.12389. Epub 2016 Sep 14.

PMID:
27625009
8.

Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa.

Wandeler G, Gsponer T, Mulenga L, Garone D, Wood R, Maskew M, Prozesky H, Hoffmann C, Ehmer J, Dickinson D, Davies MA, Egger M, Keiser O; IeDEA Southern Africa Collaboration.

AIDS. 2013 Sep 10;27(14):2225-32. doi: 10.1097/QAD.0b013e328362d887.

9.

CD4+ gain percentile curves for monitoring response to antiretroviral therapy in HIV-infected adults.

Yotebieng M, Maskew M, Van Rie A.

AIDS. 2015 Jun 1;29(9):1067-75. doi: 10.1097/QAD.0000000000000649.

10.

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.

Nash D, Katyal M, Brinkhof MW, Keiser O, May M, Hughes R, Dabis F, Wood R, Sprinz E, Schechter M, Egger M; ART-LINC Collaboration of IeDEA.

AIDS. 2008 Nov 12;22(17):2291-302. doi: 10.1097/QAD.0b013e3283121ca9.

11.

No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.

Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N, Gerstoft J.

HIV Med. 2013 Jul;14(6):362-9. doi: 10.1111/hiv.12016. Epub 2013 Feb 21.

12.

Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.

Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, Amani-Bosse C, Minga A, Messou E, Sow PS, Lewden C, Traoré HA, Bissagnene E, Dabis F; IeDEA West Africa Collaboration.

Trop Med Int Health. 2010 Jun;15 Suppl 1:34-42. doi: 10.1111/j.1365-3156.2010.02505.x.

13.

Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals.

Mussini C, Cossarizza A, Sabin C, Babiker A, De Luca A, Bucher HC, Fisher M, Rezza G, Porter K, Dorrucci M; CASCADE Collaboration.

AIDS. 2011 May 15;25(8):1041-9. doi: 10.1097/QAD.0b013e3283463ec5.

PMID:
21412128
14.

Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.

Mutimura E, Addison D, Anastos K, Hoover D, Dusingize JC, Karenzie B, Izimukwiye I, Mutesa L, Nsanzimana S, Nash D; IeDEA Central Africa Collaboration.

AIDS. 2015 Jan 2;29(1):67-76. doi: 10.1097/QAD.0000000000000520.

15.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X.

N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.

16.

Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.

Nash D, Wu Y, Elul B, Hoos D, El Sadr W; International Center for AIDS Care and Treatment Programs.

AIDS. 2011 Jul 31;25(12):1523-33. doi: 10.1097/QAD.0b013e32834811b2.

17.

Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.

Bohlius J, Valeri F, Maskew M, Prozesky H, Garone D, Sengayi M, Fox MP, Davies MA, Egger M.

Int J Cancer. 2014 Dec 1;135(11):2644-52. doi: 10.1002/ijc.28894. Epub 2014 May 2.

18.

Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort.

Balestre E, Ekouevi DK, Tchounga B, Eholie SP, Messou E, Sawadogo A, Thiébaut R, May MT, Sterne JA, Dabis F; International Epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration.

J Int AIDS Soc. 2016 Feb 8;19(1):20044. doi: 10.7448/IAS.19.1.20044. eCollection 2016.

19.

Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.

Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, Dicko F, Davies MA, Kariminia A, Wools-Kaloustian K, Aka E, Phiri S, Aurpibul L, Yiannoutsos C, Signaté-Sy H, Mofenson L, Dabis F; International IeDEA Pediatric Working Group1.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):208-19. doi: 10.1097/QAI.0b013e31827b70bf.

20.

Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion.

Bachmann MO, Timmerman V, Fairall LR.

AIDS. 2015 Nov;29(17):2261-8. doi: 10.1097/QAD.0000000000000806.

PMID:
26544699

Supplemental Content

Support Center